Literature DB >> 15772342

The rod photoreceptor pattern is set at the optic vesicle stage and requires spatially restricted cVax expression.

Dorothea Schulte1, Maureen A Peters, Jonaki Sen, Constance L Cepko.   

Abstract

How and when positional identities in the neural retina are established have been addressed primarily with respect to the topographic projections of retinal ganglion cells onto their targets in the brain. Although retinotectal map formation is a prominent manifestation of retinal patterning, it is not the only one. Photoreceptor subtypes are arranged in distinct, species-specific patterns. The mechanisms used to establish photoreceptor patterns have been relatively unexplored at the mechanistic level. We performed ablations of the eye anlage in chickens and found that removal of the anterior or dorsal optic vesicle caused loss of the area centralis, which is a rod-free central area of the retina, and severely disorganized other aspects of the rod pattern. These observations indicate that the anteroposterior and dorsoventral distribution of rods is determined by the optic vesicle stage. To investigate the molecular mechanisms involved, the rod distribution was analyzed after viral misexpression of several patterning genes that were previously shown to be important in positional specification of retinal ganglion cells. Ectopic expression of FoxG1, SOHo1,or GH6 transcription factors expressed in the anterior optic vesicle and/or optic cup, respectively, did not affect the rod pattern. This pattern therefore appears to be specified by an activity acting before, or in parallel with, these factors. In contrast, misexpression of the ventrally restricted transcription factor, cVax, severely disturbed the rod pattern.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772342      PMCID: PMC6725138          DOI: 10.1523/JNEUROSCI.2037-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

Review 1.  Confronting complexity: strategies for understanding the microcircuitry of the retina.

Authors:  R H Masland; E Raviola
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

2.  Expression of the Vax family homeobox genes suggests multiple roles in eye development.

Authors:  K Ohsaki; T Morimitsu; Y Ishida; R Kominami; N Takahashi
Journal:  Genes Cells       Date:  1999-05       Impact factor: 1.891

3.  Tbx5 and the retinotectum projection.

Authors:  K Koshiba-Takeuchi; J K Takeuchi; K Matsumoto; T Momose; K Uno; V Hoepker; K Ogura; N Takahashi; H Nakamura; K Yasuda; T Ogura
Journal:  Science       Date:  2000-01-07       Impact factor: 47.728

4.  Modulation of EphA receptor function by coexpressed ephrinA ligands on retinal ganglion cell axons.

Authors:  M R Hornberger; D Dütting; T Ciossek; T Yamada; C Handwerker; S Lang; F Weth; J Huf; R Wessel; C Logan; H Tanaka; U Drescher
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

5.  Tbx12, a novel T-box gene, is expressed during early stages of heart and retinal development.

Authors:  C T Carson; E R Kinzler; B A Parr
Journal:  Mech Dev       Date:  2000-08       Impact factor: 1.882

6.  Topographic mapping from the retina to the midbrain is controlled by relative but not absolute levels of EphA receptor signaling.

Authors:  A Brown; P A Yates; P Burrola; D Ortuño; A Vaidya; T M Jessell; S L Pfaff; D D O'Leary; G Lemke
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

7.  Misexpression of the Emx-related homeobox genes cVax and mVax2 ventralizes the retina and perturbs the retinotectal map.

Authors:  D Schulte; T Furukawa; M A Peters; C A Kozak; C L Cepko
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

8.  Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping.

Authors:  D A Feldheim; Y I Kim; A D Bergemann; J Frisén; M Barbacid; J G Flanagan
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

9.  Spatial and temporal expression of short, long/medium, or both opsins in human fetal cones.

Authors:  M Xiao; A Hendrickson
Journal:  J Comp Neurol       Date:  2000-10-02       Impact factor: 3.215

10.  A homeobox gene, vax2, controls the patterning of the eye dorsoventral axis.

Authors:  A M Barbieri; G Lupo; A Bulfone; M Andreazzoli; M Mariani; F Fougerousse; G G Consalez; G Borsani; J S Beckmann; G Barsacchi; A Ballabio; S Banfi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

View more
  6 in total

Review 1.  Early divergence of central and peripheral neural retina precursors during vertebrate eye development.

Authors:  Sara J Venters; Takashi Mikawa; Jeanette Hyer
Journal:  Dev Dyn       Date:  2014-11-17       Impact factor: 3.780

2.  Position along the nasal/temporal plane affects synaptic development by adult photoreceptors, revealed by micropatterning.

Authors:  Frank Kung; Jianfeng Wang; Raquel Perez-Castillejos; Ellen Townes-Anderson
Journal:  Integr Biol (Camb)       Date:  2015-01-23       Impact factor: 2.192

3.  Fgf8 Expression and Degradation of Retinoic Acid Are Required for Patterning a High-Acuity Area in the Retina.

Authors:  Susana da Silva; Constance L Cepko
Journal:  Dev Cell       Date:  2017-06-22       Impact factor: 12.270

4.  Genetic Dissection of Dual Roles for the Transcription Factor six7 in Photoreceptor Development and Patterning in Zebrafish.

Authors:  Mailin Sotolongo-Lopez; Karen Alvarez-Delfin; Carole J Saade; Daniel L Vera; James M Fadool
Journal:  PLoS Genet       Date:  2016-04-08       Impact factor: 5.917

5.  Central and peripheral retina arise through distinct developmental paths.

Authors:  Sara J Venters; Takashi Mikawa; Jeanette Hyer
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

6.  Progenitor cells of the rod-free area centralis originate in the anterior dorsal optic vesicle.

Authors:  Sae Kyung Shin; Keely M Bumsted O'Brien
Journal:  BMC Dev Biol       Date:  2009-11-25       Impact factor: 1.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.